Scientist

Piramal Group is a global business conglomerate with interests in Pharma, Financial Services, Information Management, Glass Packaging and Real Estate.  The Group’s flagship company, Piramal Enterprises Limited, generates more than 51% of its revenues from international markets.  Piramal Foundation runs sustainable development programmes across healthcare, education and water resources. Piramal Sarvajal and Piramal Swasthya, initiatives of the Foundation, are case studies at the Harvard Business School.

Post : Senior Principal Scientist

Conceives experimental strategies and leads and participates in the design and conduct of experiments in biological systems to characterize and validate novel targets and test efficacy of potential therapeutics to prioritize them for further development in a variety of disease areas. Possesses knowledge of relevant experimental biology techniques, possibly including: molecular biology techniques, in vitro binding, biochemical and cell- based assays, cell culture, pharmacologic dosing, disease model testing, PK and metabolism methodologies.  Participates in technology development in the area of in vitro assays, cell biology or in vivo testing. Interprets, communicates experimental findings and documents according to approved Nektar policy. Maintains broad knowledge of state-of-the-art principles and theories, and develops and analyzes new product concepts by reviewing preclinical and clinical literature. May lead discovery teams, as necessary. Mentors and guides junior scientists and may manage research associates.   This position contributes to and supports the company’s research and development efforts to create high value therapeutics to address unmet medical needs.

Post: Scientist II

The ICMR has always attempted to address itself to the growing demands of scientific advances in biomedical research on the one hand, and to the need of finding practical solutions to the health problems of the country, on the other. The ICMR has come a long way from the days when it was known as the IRFA, but the Council is conscious of the fact that it still has miles to go in pursuit of scientific achievements as well as health targets.

Following posts are to be filled purely on temporary basis at ICMR Hqrs Office, New Delhi under Research Management Policy, Planning and Coordination (RMPPC) related activities initially for a period of one year, may be extended for one more year.

Post : Scientist C (Non-Medical) - One

Applications are invited to fill up the following posts on deputation/transfer basis for one year in the Climate Change Cell of Environment Department Haryana:

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds.  Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a number of life saving original research molecules.

Post : Assistant Scientist

Johnson & Johnson was founded more than 120 years ago on a revolutionary idea: Doctors and nurses should use sterile sutures, dressings and bandages to treat peoples’ wounds.  Johnson & Johnson is ranked by Fortune Magazine as the 3rd most Admired Pharmaceutical Company in the world with an outstanding product range as well as an extensive research base with a number of life saving original research molecules.

Post : Scientist

CPhI’s 7th Annual Pharma IPR Conference happening on 7-9 March 2018, Mumbai is a leading platform for Indian pharmaceutical companies to interact with the IP Attorneys and Counsels from across the globe and discuss the recent trends and best practices in the pharma IPR space. Since 2012, Pharma IPR Conference has focused on importance of Intellectual Property in Pharma syncing it with business objectives of Indian Pharma companies.  This three-day conference will provide ample opportunities for business networking with visionary entrepreneurs and industry experts around the world.

Data Integrity (DI) has become a focal point of FDA inspections, as is evidenced by the number of warning letters citing data integrity and the resulting number of import alerts. Company Quality Management Systems are being scrutinized as to how the integrity of raw data (both electronic and manual) generated in the Quality Control Laboratory and in Operations (Manufacturing and Engineering) can be assured. The FDA is now including recommendations for recipients to obtain 3rd party assistance when addressing DI issues.  Indicators of potential Data Integrity issues are an unreasonably low number of deviations, OOS incidents and EM excursions.  Regulatory non-compliance is always a serious area of concern for the Indian pharmaceutical sector. With 13 warning letters being issued in FY 2015 and 9 warning letters in FY 2016, Data Integrity still continues to be a severe problem to be tackled.

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities. The state-of-the-art research facilities have been qualified by various pharmaceutical majors & regulatory agencies.

Post : Associate/Senior Associate Scientist- Formulation